East Sussex, United Kingdom

Donald J Lehmann

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald J Lehmann. Retrieved from https://idiyas.com/inventor/donald-j-lehmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Donald J Lehmann

Introduction

Donald J Lehmann is a notable inventor based in East Sussex, GB. He has made significant contributions to the field of medical research, particularly in understanding the genetic factors associated with late-onset Alzheimer's disease. His work has the potential to impact the lives of many individuals at risk of this condition.

Latest Patents

Lehmann holds a patent for a method that determines the propensity for developing late-onset Alzheimer's disease. This innovative method identifies the presence of specific genes in a human subject, namely the gene for butyrylcholinesterase K variant and the gene for apolipoprotein E4. The presence of these genes indicates a predisposition to develop this form of Alzheimer's disease, providing valuable insights for early intervention and treatment.

Career Highlights

Lehmann is associated with Bristol-Myers Squibb Company, where he applies his expertise in genetics and medical research. His work at this prominent pharmaceutical company allows him to collaborate with other leading scientists and contribute to groundbreaking research in the field.

Collaborations

Some of his notable coworkers include Carole Johnston and Anthony David Smith. Their collaborative efforts enhance the research environment and foster innovation in the study of Alzheimer's disease.

Conclusion

Donald J Lehmann's contributions to the understanding of late-onset Alzheimer's disease through his innovative patent highlight his role as a significant figure in medical research. His work continues to pave the way for advancements in the field, ultimately benefiting those at risk of this debilitating condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…